Circulating tumor DNA

There are 68 papers on circulating tumor DNA in aging research: 9 observational studies in people, 1 in cells, 58 reviews.

Biomarker

68 papers study it17 more mention it9 findings

MeSH

13 new papers in 30 daysSee all 85 papers on circulating tumor DNA

“Clinical testing demonstrates an area under the curve (AUC) of 0.97 for ctDNA detection in CRC patients.”
Methyltransferase-assisted single duplex sequencing for detecting circulating tumor DNAEMBO molecular medicine2026doi:10.1038/s44321-026-00509-2
  • Humans9
  • Cells1

Upstream

1

Clonal hematopoiesis clone size

no changein humans1

1 study
  1. Clonal hematopoiesis clone size was not clearly linked with circulating tumor DNA in humans (High-risk primary large B-cell lymphoma).

    HumansHigh-risk primary large B-cell lymphoma

More on Clonal hematopoiesis clone size

Associations

7

Colorectal cancer

upin humans2

2 studies
  1. Circulating tumor DNA predicts colorectal cancer in humans (for early CRC detection in asymptomatic adults) (sensitivity 0.887, specificity 0.913).

    Reviewfor early CRC detection in asymptomatic adults

  2. Circulating tumor DNA predicts colorectal cancer in humans (invasive colorectal cancer screening) (AUC 0.92, sensitivity 0.72, specificity 0.91).

    Reviewinvasive colorectal cancer screening

More on Colorectal cancer

MASD-seq

upin humans1

1 study
  1. MASD-seq predicts circulating tumor DNA in CRC patients (AUC 0.97).

    Humansin CRC patients

Disease recurrence

upin humans1

1 study
  1. Circulating tumor DNA predicts disease recurrence in humans (colorectal cancer).

    Reviewcolorectal cancer

Advanced precancerous lesions

upin humans1

1 study
  1. Circulating tumor DNA predicts advanced precancerous lesions in humans (advanced precancerous lesions screening) (sensitivity 0.13 (95% CI 0.12-0.14), specificity 0.90 (95% CI 0.88-0.91)).

    Reviewadvanced precancerous lesions screening

More on Advanced precancerous lesions

Tumor burden and treatment response monitoring

mixedin humans1

1 study
  1. Circulating tumor DNA predicts tumor burden and treatment response monitoring in humans (gastrointestinal cancers).

    Reviewgastrointestinal cancers

Colorectal cancer recurrence

upin humans1

1 study
  1. Circulating tumor DNA predicts colorectal cancer recurrence in humans After treatment of localized colorectal cancer.

    ReviewAfter treatment of localized colorectal cancer

More on Colorectal cancer recurrence

Recurrence

upin humans1

1 study
  1. Circulating tumor DNA predicts Recurrence in humans (primary or adjuvant therapy for HCC).

    Reviewprimary or adjuvant therapy for HCC

More on Recurrence

Funding

7 grants since 2017

National Cancer Institute$3.3MAmerican Cancer Society1.2MOffice of the President, University of California$98.8K

Latest

Dec 2025: 1Jan 2026: 10Feb 2026: 15Mar 2026: 13Apr 2026: 3May 2026: 1Jun 2026: 4Jul 2026: 2Aug 2026: 7Sep 2026: 9Oct 2026: 8Nov 2026: 780 papers in 12 months

See all 85 papers on circulating tumor DNA